India's Wanbury rises after Maharashtra facility gets U.S. FDA nod

Wanbury

23/08/2024 06:57

** Shares of Wanbury  WANB.NS  rise 4.45% to 218.49 rupees
    ** Pharma co gets establishment inspection report (EIR) from
U.S. FDA for its Maharashtra facility
    ** Inspection classified as "no action indicated" with "zero
Form-483 observations"
    ** Zero Form-483 observations indicate the facility is in
acceptable state of compliance with current good manufacturing
practices
    ** Stock up about 17% this week, on course for best weekly
performance since September 2023 - NSE data

 (Reporting by Bharath Rajeswaran in Bengaluru)
 ((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))